Short Bowel Syndrome clinical trials at UCSF
1 research study open to eligible people
Short bowel syndrome is a condition where part of the small intestine is missing or not working. UCSF is testing a device called Eclipse XL1 to see if it can safely help intestines grow longer in both adults and children. This trial is looking closely at how safe and helpful this new method is.
Showing trials for
Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
open to eligible people ages 12 months to 65 years
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients with Short Bowel Syndrome
San Francisco, California and other locations
Our lead scientists for Short Bowel Syndrome research studies include Matthew Lin, MD.
Last updated: